Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III.
Diagnostics (Basel). 2022 Apr 19;12(5):1027. doi: 10.3390/diagnostics12051027.
Diagnostics (Basel). 2022.
PMID: 35626183
Free PMC article.
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.
Zellinger B, Bodenhofer U, Engländer IA, Kronberger C, Grambozov B, Ruznic E, Stana M, Karner J, Fastner G, Sotlar K, Sedlmayer F, Zehentmayr F.
Zellinger B, et al. Among authors: ruznic e.
Breast Cancer. 2022 Mar;29(2):274-286. doi: 10.1007/s12282-021-01308-y. Epub 2021 Dec 5.
Breast Cancer. 2022.
PMID: 34865205
Free PMC article.
Item in Clipboard
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.
Grambozov B, Stana M, Kaiser B, Karner J, Gerum S, Ruznic E, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F.
Grambozov B, et al. Among authors: ruznic e.
Cancers (Basel). 2022 Jan 23;14(3):573. doi: 10.3390/cancers14030573.
Cancers (Basel). 2022.
PMID: 35158841
Free PMC article.
Review.
Item in Clipboard
Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR).
Zehentmayr F, Feurstein P, Ruznic E, Langer B, Grambozov B, Klebermass M, Hüpfel H, Feichtinger J, Minasch D, Heilmann M, Breitfelder B, Steffal C, Gastinger-Grass G, Kirchhammer K, Kazil M, Stranzl H, Dieckmann K; ALLSTAR group.
Zehentmayr F, et al. Among authors: ruznic e.
Radiother Oncol. 2024 Apr 21;196:110294. doi: 10.1016/j.radonc.2024.110294. Online ahead of print.
Radiother Oncol. 2024.
PMID: 38653380
Free article.
Item in Clipboard
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.
Grambozov B, Kalantari F, Beheshti M, Stana M, Karner J, Ruznic E, Zellinger B, Sedlmayer F, Rinnerthaler G, Zehentmayr F.
Grambozov B, et al. Among authors: ruznic e.
Radiother Oncol. 2023 Aug;185:109728. doi: 10.1016/j.radonc.2023.109728. Epub 2023 Jun 9.
Radiother Oncol. 2023.
PMID: 37301259
Free article.
Item in Clipboard
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate.
Stana M, Grambozov B, Karner J, Gollner I, Gaisberger C, Ruznic E, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F.
Stana M, et al. Among authors: ruznic e.
Cancers (Basel). 2023 Mar 25;15(7):1966. doi: 10.3390/cancers15071966.
Cancers (Basel). 2023.
PMID: 37046627
Free PMC article.
Item in Clipboard
Cite
Cite